<p>CARGO Therapeutics（纳斯达克代码：CRGX - 获取免费报告）在周四发布给投资者的研究报告中，被 HC Wainwright 的股票研究分析师将评级从 “买入” 下调至 “中性”，Marketbeat Ratings 报道。</p>
<p>获取 <strong>CARGO Therapeutics</strong> 的提醒：</p>
<ul>
<li>2024 年 IPO 观察：哪些新股票将上市？</li>
</ul>
<p>其他一些股票分析师最近也对 CRGX 发布了报告。Chardan Capital 在 11 月 13 日的研究报告中重申了 “买入” 评级，并对 CARGO Therapeutics 的股票设定了 28.00 美元的目标价。William Blair 在 11 月 26 日的报告中开始覆盖 CARGO Therapeutics，并对该股票给予了 “跑赢大盘” 的评级。一位投资分析师对该股票给予了卖出评级，六位分析师则给予了持有评级。根据 MarketBeat.com 的数据，该公司目前的平均评级为 “持有”，共识目标价为 15.00 美元。</p>
<p><strong>阅读我们关于 CARGO Therapeutics 的最新研究报告</strong></p>
<h2>CARGO Therapeutics 股票表现</h2>
<p>纳斯达克 CRGX 在周四开盘价为 13.19 美元。该公司的市值为 6.0714 亿美元，市盈率为-3.10，贝塔值为 2.50。该股票的 50 日移动平均价为 14.83 美元，200 日移动平均价为 17.45 美元。CARGO Therapeutics 的年低为 10.91 美元，年高为 33.92 美元。</p>
<p>CARGO Therapeutics（纳斯达克代码：CRGX - 获取免费报告）最近在 11 月 12 日发布了季度财报。该公司报告季度每股收益为（0.88 美元），超出市场共识预期的（1.14 美元）0.26 美元。股票分析师平均预测 CARGO Therapeutics 在当前财年将发布-3.73 美元的每股收益。</p>
<h2>机构资金流入和流出</h2>
<p>一些对冲基金最近对 CRGX 的持仓进行了调整。FMR LLC 在第三季度将其在 CARGO Therapeutics 的持股增加了 1.1%。FMR LLC 目前拥有 6,954,476 股该公司的股票，价值 1.2831 亿美元，此前在上个季度购买了 77,508 股。RTW Investments LP 在第三季度将其在 CARGO Therapeutics 的持仓提高了 0.5%。RTW Investments LP 目前拥有 4,098,955 股该公司的股票，价值 7562.6 万美元，此前在该期间购买了 20,833 股。Janus Henderson Group PLC 在第三季度将其在 CARGO Therapeutics 的股份增加了 1.8%。Janus Henderson Group PLC 目前拥有 2,675,285 股该公司的股票，价值 4933.5 万美元，此前在上个季度购买了 46,659 股。Wellington Management Group LLP 在第三季度将其在 CARGO Therapeutics 的持股增加了 4.1%。Wellington Management Group LLP 目前拥有 2,042,723 股该公司的股票，价值 3768.8 万美元，此前在该期间购买了 79,782 股。最后，State Street Corp 在第三季度将其在 CARGO Therapeutics 的股份增加了 11.7%。State Street Corp 目前拥有 839,861 股该公司的股票，价值 1549.5 万美元，此前在上个季度购买了 88,000 股。目前 93.16% 的股票由机构投资者持有。</p>
<h2>关于 CARGO Therapeutics</h2>
<p>（获取免费报告）</p>
<p>CARGO Therapeutics, Inc 是一家临床阶段的生物技术公司，开发用于癌症患者的嵌合抗原受体（CAR）T 细胞疗法。该公司的主导项目是 CRG-022，一种自体 CD22 CAR T 细胞产品候选药物，旨在通过靶向 CD22 这一在 B 细胞恶性肿瘤中表达的替代肿瘤抗原来应对耐药机制。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更看好的五只股票，而不是 CARGO Therapeutics</li>
<li>股票市场行业：它们是什么以及有多少个？</li>
<li>金佰利：在这位股息之王中获得的绝佳机会</li>
<li>3 只小盘股具有巨大的回报潜力</li>
<li>5 只股票的收益率高于市场，刚刚提高了支付</li>
<li>使用 MarketBeat 股息收益率计算器</li>
<li>Arista Networks 的股票暴跌：投资者的买入机会？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q1JHWA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q1JHWA"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对本故事有任何问题或意见，请发送电子邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元在 CARGO Therapeutics 吗？</h2>
<p>在你考虑 CARGO Therapeutics 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场关注之前立即购买……而 CARGO Therapeutics 并不在名单上。</p>
<p>虽然 CARGO Therapeutics 目前在分析师中获得了 “减持” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

CRGX

<p>CARGO Therapeutics（纳斯达克代码：CRGX）被 HC Wainwright 从 “买入” 评级下调至 “中性” 评级。该公司的平均评级为 “持有”，共识目标价为 15.00 美元。CARGO 的股票开盘价为 13.19 美元，市值为 6.0714 亿美元。最近的季度财报显示每股亏损为（0.88 美元），超出预期。机构投资者持有 93.16% 的股份，尽管评级下调，但仍显示出强烈的机构兴趣</p>

<p>CARGO Therapeutics (NASDAQ:CRGX - Get Free Report) was downgraded by equities research analysts at HC Wainwright from a &#34;buy&#34; rating to a &#34;neutral&#34; rating in a research note issued to investors on Thursday, Marketbeat Ratings reports.</p>
<div class="lb-trans"><p>CARGO Therapeutics（纳斯达克代码：CRGX - 获取免费报告）在周四发布给投资者的研究报告中，被 HC Wainwright 的股票研究分析师将评级从 “买入” 下调至 “中性”，Marketbeat Ratings 报道。</p>
</div><p>Get <strong>CARGO Therapeutics</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>CARGO Therapeutics</strong> 的提醒：</p>
</div><ul>
<li>IPO watch 2024: Which new stocks will hit the market?</li>
</ul>
<div class="lb-trans"><ul>
<li>2024 年 IPO 观察：哪些新股票将上市？</li>
</ul>
</div><p>A number of other equities analysts also recently issued reports on CRGX. Chardan Capital restated a &#34;buy&#34; rating and issued a $28.00 price target on shares of CARGO Therapeutics in a research note on Wednesday, November 13th. William Blair assumed coverage on CARGO Therapeutics in a report on Tuesday, November 26th. They issued an &#34;outperform&#34; rating on the stock. One investment analyst has rated the stock with a sell rating and six have assigned a hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of &#34;Hold&#34; and a consensus target price of $15.00.</p>
<div class="lb-trans"><p>其他一些股票分析师最近也对 CRGX 发布了报告。Chardan Capital 在 11 月 13 日的研究报告中重申了 “买入” 评级，并对 CARGO Therapeutics 的股票设定了 28.00 美元的目标价。William Blair 在 11 月 26 日的报告中开始覆盖 CARGO Therapeutics，并对该股票给予了 “跑赢大盘” 的评级。一位投资分析师对该股票给予了卖出评级，六位分析师则给予了持有评级。根据 MarketBeat.com 的数据，该公司目前的平均评级为 “持有”，共识目标价为 15.00 美元。</p>
</div><p><strong>Read Our Latest Research Report on CARGO Therapeutics</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于 CARGO Therapeutics 的最新研究报告</strong></p>
</div><h2>CARGO Therapeutics Stock Performance</h2>
<div class="lb-trans"><h2>CARGO Therapeutics 股票表现</h2>
</div><p>NASDAQ CRGX opened at $13.19 on Thursday. The company has a market capitalization of $607.14 million, a price-to-earnings ratio of -3.10 and a beta of 2.50. The stock has a 50-day moving average of $14.83 and a 200 day moving average of $17.45. CARGO Therapeutics has a one year low of $10.91 and a one year high of $33.92.</p>
<div class="lb-trans"><p>纳斯达克 CRGX 在周四开盘价为 13.19 美元。该公司的市值为 6.0714 亿美元，市盈率为-3.10，贝塔值为 2.50。该股票的 50 日移动平均价为 14.83 美元，200 日移动平均价为 17.45 美元。CARGO Therapeutics 的年低为 10.91 美元，年高为 33.92 美元。</p>
</div><p>CARGO Therapeutics (NASDAQ:CRGX - Get Free Report) last released its quarterly earnings data on Tuesday, November 12th. The company reported ($0.88) earnings per share for the quarter, beating the consensus estimate of ($1.14) by $0.26. On average, equities analysts predict that CARGO Therapeutics will post -3.73 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>CARGO Therapeutics（纳斯达克代码：CRGX - 获取免费报告）最近在 11 月 12 日发布了季度财报。该公司报告季度每股收益为（0.88 美元），超出市场共识预期的（1.14 美元）0.26 美元。股票分析师平均预测 CARGO Therapeutics 在当前财年将发布-3.73 美元的每股收益。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>A number of hedge funds have recently made changes to their positions in CRGX. FMR LLC lifted its holdings in CARGO Therapeutics by 1.1% during the third quarter. FMR LLC now owns 6,954,476 shares of the company's stock valued at $128,310,000 after purchasing an additional 77,508 shares in the last quarter. RTW Investments LP raised its position in shares of CARGO Therapeutics by 0.5% during the 3rd quarter. RTW Investments LP now owns 4,098,955 shares of the company's stock valued at $75,626,000 after purchasing an additional 20,833 shares during the period. Janus Henderson Group PLC lifted its stake in shares of CARGO Therapeutics by 1.8% during the 3rd quarter. Janus Henderson Group PLC now owns 2,675,285 shares of the company's stock valued at $49,335,000 after buying an additional 46,659 shares in the last quarter. Wellington Management Group LLP boosted its holdings in CARGO Therapeutics by 4.1% in the 3rd quarter. Wellington Management Group LLP now owns 2,042,723 shares of the company's stock worth $37,688,000 after buying an additional 79,782 shares during the period. Finally, State Street Corp increased its stake in CARGO Therapeutics by 11.7% in the 3rd quarter. State Street Corp now owns 839,861 shares of the company's stock worth $15,495,000 after buying an additional 88,000 shares in the last quarter. 93.16% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>一些对冲基金最近对 CRGX 的持仓进行了调整。FMR LLC 在第三季度将其在 CARGO Therapeutics 的持股增加了 1.1%。FMR LLC 目前拥有 6,954,476 股该公司的股票，价值 1.2831 亿美元，此前在上个季度购买了 77,508 股。RTW Investments LP 在第三季度将其在 CARGO Therapeutics 的持仓提高了 0.5%。RTW Investments LP 目前拥有 4,098,955 股该公司的股票，价值 7562.6 万美元，此前在该期间购买了 20,833 股。Janus Henderson Group PLC 在第三季度将其在 CARGO Therapeutics 的股份增加了 1.8%。Janus Henderson Group PLC 目前拥有 2,675,285 股该公司的股票，价值 4933.5 万美元，此前在上个季度购买了 46,659 股。Wellington Management Group LLP 在第三季度将其在 CARGO Therapeutics 的持股增加了 4.1%。Wellington Management Group LLP 目前拥有 2,042,723 股该公司的股票，价值 3768.8 万美元，此前在该期间购买了 79,782 股。最后，State Street Corp 在第三季度将其在 CARGO Therapeutics 的股份增加了 11.7%。State Street Corp 目前拥有 839,861 股该公司的股票，价值 1549.5 万美元，此前在上个季度购买了 88,000 股。目前 93.16% 的股票由机构投资者持有。</p>
</div><h2>About CARGO Therapeutics</h2>
<div class="lb-trans"><h2>关于 CARGO Therapeutics</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>CARGO Therapeutics, Inc, a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients. The company's lead program is CRG-022, an autologous CD22 CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in B-cell malignancies.</p>
<div class="lb-trans"><p>CARGO Therapeutics, Inc 是一家临床阶段的生物技术公司，开发用于癌症患者的嵌合抗原受体（CAR）T 细胞疗法。该公司的主导项目是 CRG-022，一种自体 CD22 CAR T 细胞产品候选药物，旨在通过靶向 CD22 这一在 B 细胞恶性肿瘤中表达的替代肿瘤抗原来应对耐药机制。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than CARGO Therapeutics</li>
<li>Stock Market Sectors: What Are They and How Many Are There?</li>
<li>Kimberly-Clark: A Regal Opportunity in This Dividend King</li>
<li>3 Small Caps With Big Return Potential</li>
<li>5 Stocks With Above-Market Yields Just Raised Payments Further</li>
<li>Using the MarketBeat Dividend Yield Calculator</li>
<li>Arista Networks' Stock Plunge: Buying Opportunity for Investors?</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，而不是 CARGO Therapeutics</li>
<li>股票市场行业：它们是什么以及有多少个？</li>
<li>金佰利：在这位股息之王中获得的绝佳机会</li>
<li>3 只小盘股具有巨大的回报潜力</li>
<li>5 只股票的收益率高于市场，刚刚提高了支付</li>
<li>使用 MarketBeat 股息收益率计算器</li>
<li>Arista Networks 的股票暴跌：投资者的买入机会？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q1JHWA" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NASDAQ&amp;Symbol=CRGX"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对本故事有任何问题或意见，请发送电子邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in CARGO Therapeutics Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 CARGO Therapeutics 吗？</h2>
</div><p>Before you consider CARGO Therapeutics, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 CARGO Therapeutics 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CARGO Therapeutics wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场关注之前立即购买……而 CARGO Therapeutics 并不在名单上。</p>
</div><p>While CARGO Therapeutics currently has a &#34;Reduce&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 CARGO Therapeutics 目前在分析师中获得了 “减持” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Cargo Therapeutics（纳斯达克股票代码：CRGX）被 HC Wainwright 下调至 “中性” 评级